Graft-versus-host disease in multiple myeloma patients treated with daratumumab after allogeneic transplantation

ConclusionsOur results demonstrate that the incidence of GVHD after daratumumab is low and did not result in increased exacerbation of GVHD in patients with prior history of GVHD.

Source: Clinical Lymphoma Myeloma and Leukemia - January 28, 2020 Category: Cancer & Oncology Source Type: research